Based on the results of the functional enrichment and pathway analysis of ACACB, further explorations of related signaling pathways were performed to confirm the potential mechanisms between ACACB expression and cetuximab sensitivity in different CRC cell lines. This evidence concerns the gene ACACB and colorectal carcinoma.